Plasma Exchange
TPE, plasmapheresis, young plasma, albumin
01. Overview
Therapeutic plasma exchange research explores whether circulating pro-aging factors can be diluted or removed to improve function, inflammation, and tissue recovery. It sits at the boundary of translational science and frontier intervention.
It is a highly differentiated category with intense interest from longevity clinics, but the literature still needs careful scrutiny for mechanism, safety, and durability.
Clinical theme
Therapeutic plasma exchange
Clinical theme
Albumin replacement
Clinical theme
Young plasma hypotheses
Clinical theme
Rejuvenation biology
A clinical lens on plasma exchange research
Therapeutic plasma exchange is the most ambitious longevity therapy in active human trials — read it like the frontier it is.
Use this topic to track TPE evidence as it matures from mouse parabiosis to real human protocols.
- →Frontier longevity protocol review
- →Inflammation and immune-aging context
- →Cognitive longevity strategy
- →Pre-clinical exploration
- Mechanism is biologically plausible
- Clinical signal is early but real
- Cost and access are real constraints
- Long-term safety data is incomplete
- Is this evidence ready for clinical decision-making?
- What protocol was studied?
- Is the cost-benefit defensible?
03. The Studies
0 indexedSample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation